Physician profile
Surendra Basti
NPI 1619963873
$126,463.04
in general payments reported to CMS, 2019-2025
11 companies · $17K in 2025
The $17K reported for 2025 was more than what 96% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28K · 2020: $1,050 · 2021: $18K · 2022: $23K · 2023: $25K · 2024: $14K · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $32K · Grant: $17K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,000 · Travel and Lodging: $2,514 · Food and Beverage: $1,866.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $31,906.92 |
| Grant | $16,500.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,000.00 |
| Travel and Lodging | $2,513.92 |
| Food and Beverage | $1,865.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $58,836.59 | 2019-2025 | Tecnis Iol, Compact Intuitiv, Baerveldt Glaucoma Implant (250) |
| Bausch & Lomb Americas INC. | $33,416.90 | 2022-2025 | Miebo, Envista Envy Iol, Stellaris |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $30,179.47 | 2019-2021 | |
| Alcon Vision LLC | $3,394.09 | 2019-2025 | Unity, Wavelight Ex500 Excimer Laser, Clareon |
| Carl Zeiss Meditec, INC. | $260.52 | 2019-2021 | |
| Carl Zeiss Meditec USA, INC. | $123.22 | 2021-2022 | |
| Johnson & Johnson Vision Care, INC. | $94.77 | 2023-2024 | Acuvue, Veritas Vision System |
| Janssen Pharmaceuticals, INC | $75.35 | 2023 | Tecnis Iol, Veritas Vision System |
| Rxsight INC | $39.03 | 2021-2022 | |
| Beaver-Visitec International, INC. | $24.04 | 2021 | |
| Novartis Pharmaceuticals Corporation | $19.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Surendra Basti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.